Machine learning versus traditional risk stratification methods in acute coronary syndrome: a pooled randomized clinical trial analysis William J. GibsonTarek NafeeC. Michael Gibson OriginalPaper 18 September 2019 Pages: 1 - 9
Pharmacodynamic assessment of prasugrel and clopidogrel in patients with non-cardioembolic stroke: a multicenter, randomized, active-control clinical trial Takenori YamaguchiToshiaki ShiraiYasuo Ikeda OriginalPaper Open access 23 October 2019 Pages: 10 - 17
Determinants of anticoagulant therapy in atrial fibrillation at discharge from a geriatric ward: cross sectional study Z. B. WojszelA. Kasiukiewicz OriginalPaper Open access 30 August 2019 Pages: 18 - 26
Comparison of polyspecific versus IgG specific ELISA in predominately cardiac patients with suspected heparin induced thrombocytopenia Sophie SamuelMary F. McGuireAndy Nguyen OriginalPaper 24 September 2019 Pages: 27 - 33
Right ventricular dysfunction is superior and sufficient for risk stratification by a pulmonary embolism response team Yu Lin ChenColin WrightScott J. Cameron OriginalPaper 02 August 2019 Pages: 34 - 41
Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study Vincenzo RussoEmilio AttenaGerardo Nigro OriginalPaper 05 August 2019 Pages: 42 - 53
Pulmonary embolism response team implementation improves awareness and education among the house staff and faculty Yevgeniy BrailovskySiri KunchakarraAmir Darki OriginalPaper 08 August 2019 Pages: 54 - 58
Cancer-associated thromboembolism: antithrombotic management of hospitalized patients Larry K. GolightlyBonita A. SimendingerTyree H. Kiser OriginalPaper 29 August 2019 Pages: 59 - 66
ADAMTS13 activity is associated with early neurological improvement in acute ischemic stroke patients treated with intravenous thrombolysis Anne-Sophie PutzerHans WorthmannRamona Schuppner OriginalPaper 03 September 2019 Pages: 67 - 74
Age-related burden and characteristics of embolic stroke of undetermined source in the real world clinical practice Elisa GrifoniDavide GiglioLuca Masotti OriginalPaper 07 September 2019 Pages: 75 - 85
Management of oral anticoagulation in very old patients with non valvular atrial fibrillation related acute ischemic stroke Vieri VannucchiFederico MoroniLuca Masotti OriginalPaper 17 October 2019 Pages: 86 - 93
Combined effect of a direct oral anticoagulant edoxaban and an inhibitor of activated thrombin-activatable fibrinolysis inhibitor on clot lysis Yoshiyuki MorishimaChikako KamisatoYuko Honda OriginalPaper 08 August 2019 Pages: 94 - 99
The anticoagulant effect of Apis mellifera phospholipase A2 is inhibited by CORM-2 via a carbon monoxide-independent mechanism Vance G. Nielsen OriginalPaper 02 November 2019 Pages: 100 - 107
Appropriateness of thrombophilia testing in patients in the acute care setting and an evaluation of the associated costs Riddhi VirpariaLuigi BrunettiChristopher D. Adams OriginalPaper 06 August 2019 Pages: 108 - 112
Universal venous thromboembolism policy is effective but may not adequately protect hospitalized cancer patients with larger BMI Anna XuHassan SibaiJack T. Seki OriginalPaper 01 November 2019 Pages: 113 - 120
Cost comparison of andexanet versus prothrombin complex concentrates for direct factor Xa inhibitor reversal after hemorrhage Jennifer A. FronteraPrachi BhattDanielle Joset OriginalPaper 29 October 2019 Pages: 121 - 131
“Minor” stroke: not a minor, still open question Eugenia RotaNicola MorelliDonata Guidetti Letter to the Editor 29 November 2019 Pages: 132 - 135
Underuse of anticoagulant therapy in hospitalized older patients: comment on the article of Wojszel et al. Antonella MameliPaola SchirruDoris Barcellona Letter to the Editor 24 September 2019 Pages: 136 - 137
Life after abciximab; what’s next for intracoronary thrombus? D. McGhieD. AmosH. C. Lowe Letter to the Editor 25 October 2019 Pages: 138 - 140
An unusual cause of acute ischemic stroke: Adult Onset Still’s Disease Yihui GohVenetia Yunjia WongHock Luen Teoh Letter to the Editor 02 December 2019 Pages: 141 - 144
Ticagrelor and tirofiban in pregnancy and delivery: beyond labels Donatella ArgentieroStefano SavonittoFortunato Iacovelli Report 30 August 2019 Pages: 145 - 148
Warfarin induced leukocytoclastic vasculitis: an extraordinary side effect Dina ElantablyAhmed MouradMohamed Effat Report 02 August 2019 Pages: 149 - 152
Prolonged activated partial thromboplastin time after prophylactic-dose unfractionated heparin in the post-operative neurosurgical setting: case series and management recommendations Michael ShustermanNiklas GrasslMaria T. De Sancho BriefCommunication 27 August 2019 Pages: 153 - 158
A case of acute pancreatitis-induced microangiopathic hemolytic anemia with thrombocytopenia Kevin M. HillDanielle MoormanRoy Khalife BriefCommunication 06 September 2019 Pages: 159 - 163
Different manifestations of patients with inhibitors against prothrombin and thrombin Ning TangDengju Li BriefCommunication 23 September 2019 Pages: 164 - 167
Platelet reactivity in patients with chronic kidney disease and hemodialysis Philipp MourikisCarolin HeltenAmin Polzin BriefCommunication 06 November 2019 Pages: 168 - 172
Short-term dual antiplatelet therapy (DAPT) followed by P2Y12 monotherapy versus traditional DAPT in patients undergoing percutaneous coronary intervention: meta-analysis and viewpoint Bernhard WernlyRichard RezarChristian Jung BriefCommunication 04 November 2019 Pages: 173 - 176